Modulation of cell cycle-related protein expression by sodium butyrate in human non-small cell lung cancer cell lines

International Journal of Cancer

Volumn 91, Issue 5, 2001, Pages 654-657

  Pellizzaro, Cinzia ^a   Coradini, Danila ^a   Daniotti, Antonella ^a   Abolafio, Gabriella ^a   Daidone, Maria Grazia ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Cell cycle related proteins; Lung cancer cell lines; Sodium butyrate

Indexed keywords

BUTYRIC ACID; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; PROTEIN P16; PROTEIN P21; PROTEIN P27; PROTEIN P53;

ARTICLE; CANCER CELL; CANCER GROWTH; CELL CYCLE; CELL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MODULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY;

BLOTTING, WESTERN; BUTYRATES; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN D1; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; GENES, P53; HUMANS; LUNG NEOPLASMS; MICROTUBULE-ASSOCIATED PROTEINS; MUTATION; SODIUM; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 0035283749     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1117>3.0.CO;2-I     Document Type: Article

References (30)

1. Surgical treatment of lung cancer
2. Short-chain fatty acid-initiated cell cycle arrest and apoptosis of colonic epithelial cells is linked to mitochondrial function
3. Effect of 5-azacytidine and butyrate on differentiation and apoptosis of hepatic cancer cell lines
4. Butyrate-induced differentiation in leukemic myeloid cells, in vitro and itl vivo studies
5. Effect of sodium butyrate on human breast cancer cell lines
6. Butyric acid from the diet, actions at the level of gene expression
7. Arginine butyrate downregulates p210 bcr-abl expression and induces apoptosis in chronic myelogenous leukemic cells
8. 5-Fluorouracil-resistant colonic tumors are highly responsive to sodium butyrate/interleukin 2 biotherapy in rats
9. Simultaneous but not sequential treatment with sodium butyrate improves the antiproliferative effect of alpha- or beta-interferon on a breast cancer cell line
10. Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute. Anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents
11. Sodium butyrate modulates cell cycle-related proteins in HT29 human colonic adenocarcinoma cells
12. G1 cyclins and control of the cell division cycle in normal and transformed cells
13. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/cdk4
14. Establishment and identification of small cell lung cancer cell lines having classic and variant features
15. Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium
16. A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity
17. Inhibition of cell cycle progression by sodium butyrate in normal rat kidney fibroblasts is altered by expression of the adenovirus 5 early lA gene
18. Role of p53 in cell cycle regulation and apoptosis following exposure to proteasome inhibitors
19. Heterogeneity of transcriptional activity of mutant p53 proteins and p53 DNA target sequences
20. Suppression of growth of hepatocellular carcinoma by sodium butyrate in vitro and in vivo
21. Butyrate-induced G1 arrest results from p21-independent disruption of retinoblastoma protein-mediated signals
22. The role of transcriptional factor Spl in regulating the expression of the WAF1/CIP1 gene in U937 leukemic cells
23. Butyrate activates the WAF1/CIP 1 gene promoter through Sp 1 sites in a p53-negative human colon cancer cell line
24. A novel approach for cancer chemoprevention referred to as "gene-regulating chemoprevention"
25. Comparative effects of overexpression of p27Kip 1 and p21Cip 1/Wafl on the growth and differentiation in human colon carcinoma cells
26. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer
27. Reduced expression of the cell cycle inhibitor p27kipl in non-small cell lung carcinoma, a prognostic factor independent of Ras
28. Clinical pharmacology of sodium butyrate in patients with acute leukemia
29. Expression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor
30. Hyaluronic acid as drug delivery for sodium butyrate: Improvement of the antiproliferafive activity on a breast cancer cell line